Filing Flows › Indivior Pharmaceuticals (INDV) › Next earnings date
Indivior Pharmaceuticals (INDV) earnings: beat the estimate
Indivior Pharmaceuticals (INDV) reported on Oct 29, 2026 and beat the EPS estimate: $1.32 against $1.13 (+17.2%). Revenue was $356M for Q3 2026, +13% year over year. It beat the EPS estimate in 100% of the quarters on record.
The last report
Indivior Pharmaceuticals reported revenue of $356M for the third quarter 2026 (+13% Y/Y), net earnings $137M. How it makes money → · Every quarter →
Indivior Pharmaceuticals' latest quarter
Indivior Pharmaceuticals, Q3 2026: revenue $356M (+13% year over year), operating margin 50.6%, net earnings $137M, operating cash flow $97.0M. The chart follows the revenue to costs, profit and cash.
Questions
Did Indivior Pharmaceuticals beat earnings?
Indivior Pharmaceuticals (INDV) reported on Oct 29, 2026 and beat the EPS estimate: $1.32 against $1.13 (+17.2%).
When does INDV report earnings?
The next date is not set yet.
Does Indivior Pharmaceuticals usually beat earnings?
It beat the consensus EPS estimate in 100% of the quarters on record.
Updated Nov 8, 2026. Read automatically from SEC filings and public data; errors are possible. Not investment advice.